Skip to main content
NAVCO Pharmaceuticals logo

NAVCO Pharmaceuticals — Investor Relations & Filings

Ticker · NAV ISIN · CA63942R1091 LEI · 8945003WKDH61M8UB963 TSXV Manufacturing
Filings indexed 199 across all filing types
Latest filing 2019-10-01 Regulatory Filings
Country CA Canada
Listing TSXV NAV

About NAVCO Pharmaceuticals

https://www.navcopharma.com/

NAVCO Pharmaceuticals is a biotechnology company specializing in the research, development, and commercialization of nanotechnology products and materials. The company utilizes proprietary Computerized Nano-meter Algorithms to create innovative solutions for anti-viral, anti-fungal, and anti-bacterial treatments. NAVCO focuses on developing supplemental and therapeutic consumer health and wellness products. A key offering is the BioActive™ line, which includes non-toxic, non-flammable, and alcohol-free hand cleansers, creams, and surface disinfectants designed to provide extended protection against germs and microorganisms. These nanotechnology products are marketed across various sectors, including medicine and textiles, providing next-generation protection solutions for multiple industries.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2019-10-01 English
Notice of meeting - English.pdf
Regulatory Filings
2019-09-24 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2019-08-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2019-05-30 English
Interim MD&A - English.pdf
Regulatory Filings
2019-05-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2019-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.